Your browser doesn't support javascript.
loading
Bone marrow necrosis following ALL-trans retinoic acid therapy for acute promyelocytic leukaemia.
Dreosti, L M; Bezwoda, W; Gunter, K.
Affiliation
  • Dreosti LM; Department of Oncology, University of the Witwatersrand, Johannesburg, South Africa.
Leuk Lymphoma ; 13(3-4): 353-6, 1994 Apr.
Article in En | MEDLINE | ID: mdl-8049655
ABSTRACT
Acute promyelocytic leukaemia (APL) (FAB-M3) is associated with fatal haemorrhagic complications in 10 to 20% of patients. Recently ALL-Trans Retinoic acid (ALL-Trans RA) therapy has been used with rapid correction of the coagulopathy. Although minimal haematologic toxicity has been reported, a number of potentially serious side-effect have been described. We report a case of bone marrow necrosis occurring in a patient with APL treated with ALL-Trans RA. The possible relationship of this complication to retinoid therapy is discussed. This patient subsequently recovered and not only achieved complete remission but tolerated two cycles of chemotherapy without problems.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Tretinoin / Bone Marrow / Leukemia, Promyelocytic, Acute / Immunologic Factors Type of study: Etiology_studies Limits: Female / Humans / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 1994 Document type: Article Affiliation country:
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Tretinoin / Bone Marrow / Leukemia, Promyelocytic, Acute / Immunologic Factors Type of study: Etiology_studies Limits: Female / Humans / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 1994 Document type: Article Affiliation country:
...